搜索临床试验以:PD-1抑制剂联合阿西替尼
总计1164个结果
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital完全的
-
Peking University Cancer Hospital & Institute招聘中
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤美国
-
Peking University Cancer Hospital & Institute主动,不招人
-
Sichuan Cancer Hospital and Research Institute主动,不招人
-
The Affiliated Hospital of Qingdao University未知
-
Tianjin Medical University Cancer Institute and...未知
-
National Cancer Institute (NCI)主动,不招人复发性儿童室管膜瘤 | 晚期恶性实体瘤 | 复发性尤文肉瘤 | 复发性肝母细胞瘤 | 复发性朗格汉斯细胞组织细胞增生症 | 复发性恶性生殖细胞肿瘤 | 复发性恶性胶质瘤 | 复发性髓母细胞瘤 | 复发性神经母细胞瘤 | 复发性非霍奇金淋巴瘤 | 复发性骨肉瘤 | 复发性外周原始神经外胚层肿瘤 | 复发性横纹肌样瘤 | 复发性横纹肌肉瘤 | 复发性软组织肉瘤 | 难治性室管膜瘤 | 难治性尤文肉瘤 | 难治性肝母细胞瘤 | 难治性朗格汉斯细胞组织细胞增生症 | 难治性恶性生殖细胞瘤 | 难治性恶性胶质瘤 | 难治性髓母细胞瘤 | 难治性神经母细胞瘤 | 难治性非霍奇金淋巴瘤 | 难治性骨肉瘤 | 难治性外周原始神经外胚层肿瘤 | 难治性横纹肌样瘤 | 难治性横纹肌肉瘤 | 难治性软组织肉瘤 | 复发性胶质瘤 | 难治性胶质瘤 | 复发性肾母细胞瘤美国, 波多黎各
-
Shanghai Zhongshan Hospital主动,不招人
-
Applied Genetic Technologies CorpFoundation Fighting Blindness完全的
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co. Ltd.未知
-
Calico Life Sciences LLCAbbVie招聘中
-
Sichuan UniversityAffiliated Hospital of North Sichuan Medical College; Affiliated Hospital of Southwest Medical...完全的
-
Pfizer终止黑色素瘤 | 软组织肉瘤 | 蕈样肉芽肿 | 乳腺癌 | 实体瘤 | 鳞状细胞癌 | 人乳头瘤病毒相关恶性肿瘤 | 默克尔细胞癌美国
-
Nanfang Hospital of Southern Medical UniversityThe Affiliated Hospital of Qingdao University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... 和其他合作者招聘中Venetoclax Combined With Azacitidine Plus Homoharringtonine | Venetoclax Combined With Azacitidine中国
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
China Medical University Hospital未知
-
Fifth Affiliated Hospital, Sun Yat-Sen University招聘中鼻咽癌 | 卡培他滨 | 放疗 | PD-1抑制剂中国
-
CARsgen Therapeutics Co., Ltd.Fudan University; Peking University Cancer Hospital & Institute招聘中